Rongpeng Gong1, Zixin Xu2, Xiaoxing Wei3. 1. Medical College of Qinghai University, Xining, Qinghai, 810016, P. R. China. 2. Shaanxi University of Chinese Medicine, Xi'an, Shaanxi, 712046, P. R. China. 3. Medical College of Qinghai University, Xining, Qinghai, 810016, P. R. China. weixiaoxing@qhu.edu.cn.
Abstract
BACKGROUND: Previous studies have shown that hyperuricemia is involved in diabetes, obesity, hypertension, chronic kidney disease, and other diseases. At the same time, studies have shown that vitamin D3 levels in the body are linked to the onset of diabetes. However, there is currently no sufficient evidence to prove whether this connection is affected by the uric acid level. Therefore, we attempted to investigate the association between vitamin D3 content and the occurrence of diabetes in populations with different uric acid levels though the data of NHANES database from 2009 to 2018. METHOD: Using the NHANES database, we performed a cross-sectional analysis. The participants were chosen based on stringent inclusion and exclusion requirements. This study finally included a total number of 16,735 individuals. Multivariate logistic regression analysis was used to investigate the association between vitamin D3 and diabetes mellitus in hyperuricemia and non-hyperuricemia patients after complete adjustment, and multivariate linear regression analysis was used to illustrate the association between vitamin D3 and uric acid. RESULT: The results showed that the association between vitamin D3 and diabetes was weakened in hyperuricemia patients (OR 0.95 (0.92,0.98)). An independent association was discovered between vitamin D3 and uric acid (β -0.12 (-0.16, -0.07)) in all groups of population. CONCLUSIONS: This study shows that vitamin D3 content is associated with the incidence of diabetes in people with high level of uric acid. This study offers a fresh perspective on the elements that influence the etiology of diabetes in hyperuricemia patients.
BACKGROUND: Previous studies have shown that hyperuricemia is involved in diabetes, obesity, hypertension, chronic kidney disease, and other diseases. At the same time, studies have shown that vitamin D3 levels in the body are linked to the onset of diabetes. However, there is currently no sufficient evidence to prove whether this connection is affected by the uric acid level. Therefore, we attempted to investigate the association between vitamin D3 content and the occurrence of diabetes in populations with different uric acid levels though the data of NHANES database from 2009 to 2018. METHOD: Using the NHANES database, we performed a cross-sectional analysis. The participants were chosen based on stringent inclusion and exclusion requirements. This study finally included a total number of 16,735 individuals. Multivariate logistic regression analysis was used to investigate the association between vitamin D3 and diabetes mellitus in hyperuricemia and non-hyperuricemiapatients after complete adjustment, and multivariate linear regression analysis was used to illustrate the association between vitamin D3 and uric acid. RESULT: The results showed that the association between vitamin D3 and diabetes was weakened in hyperuricemiapatients (OR 0.95 (0.92,0.98)). An independent association was discovered between vitamin D3 and uric acid (β -0.12 (-0.16, -0.07)) in all groups of population. CONCLUSIONS: This study shows that vitamin D3 content is associated with the incidence of diabetes in people with high level of uric acid. This study offers a fresh perspective on the elements that influence the etiology of diabetes in hyperuricemiapatients.
Entities:
Keywords:
A cross-sectional study; Diabetes mellitus; Hyperuricemia; Linear regression; Logistic regression; Vitamin D3
Authors: Andreas Stadlmayr; Elmar Aigner; Ursula Huber-Schönauer; David Niederseer; Jochen Zwerina; Emma Husar-Memmer; Florian Hohla; Georg Schett; Wolfgang Patsch; Christian Datz Journal: Acta Diabetol Date: 2014-05-22 Impact factor: 4.280
Authors: Claudia Gagnon; Robin M Daly; André Carpentier; Zhong X Lu; Catherine Shore-Lorenti; Ken Sikaris; Sonia Jean; Peter R Ebeling Journal: PLoS One Date: 2014-10-09 Impact factor: 3.240
Authors: Barbora de Courten; Aya Mousa; Negar Naderpoor; Helena Teede; Maximilian P J de Courten; Robert Scragg Journal: Trials Date: 2015-08-07 Impact factor: 2.279